SEC Form 4 · accession 0001171843-26-006235
Compass Therapeutics, Inc. · CMPX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Neil Lerner
Officer — Chief Accounting Officer
Period of report
Sep 24, 2026
Accepted (ET)
Sep 25, 2026 · 8:01 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001738021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 24, 2026 | P | 2,500 | $1.14 | A | 400,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F162,500 of the shares represents unvested restricted stock units ("RSU") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027.